Companies in the biopharma sector developing innovative solutions and technologies.
Explore 885 recently funded biopharma companies with verified founder contact information and fundraising data.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Mammogen specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end.
Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.
NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.
ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.
Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.
Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.
FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Jeeva optimizes and decentralizes clinical research to make innovation accessible to patients regardless of their location.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions.
Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.
Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 885 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked